查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541301

2024-2032 年胃肠道治疗市场报告（按类型、给药途径、应用、配销通路和地区）

Gastrointestinal Therapeutics Market Report by Type, Route of Administration, Application, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球胃肠道治疗市场规模达465亿美元。

胃肠道 (GI) 症候群是指影响消化道器官功能的医学疾病。它会影响胃、胰臟、小肠和大肠、胆囊和肝臟，通常表现为消化不良、胃灼热、便秘和腹胀。一些常用的胃肠道治疗方法包括处方药和非处方药 (OTC)，例如抗酸剂、泻药、止泻剂、止吐剂、抗溃疡剂以及内视镜和放射学检查以及血液学检查。这些疗法有助于检测疾病并吸收食物中的营养物质，以改善消化，调节胃肠道系统中的水流量并最大限度地减少胃酸度。

发炎性肠道疾病（IBD）和溃疡性结肠炎等胃肠道疾病的盛行率不断上升，是推动市场成长的关键因素之一。由于生活方式的改变和不健康的饮食习惯，全球患者疾病復发的可能性增加。此外，老年人口的增加也推动了市场的成长，老年人口更容易罹患此类疾病。各种技术进步，例如用于治疗该疾病的创新生物相似药和细胞疗法的开发，正在充当其他生长诱导因素。这些生物製剂透过静脉注射和皮下注射进行给药，并针对针对性治疗进行个人化。其他因素，包括大众健康意识的提高、广泛的研发活动以及医疗基础设施的显着改善，尤其是在发展中经济体，预计将进一步推动市场发展。

本报告回答的关键问题：

  • 迄今为止，全球胃肠道治疗市场表现如何，未来几年将如何表现？
  • COVID-19 对全球胃肠道治疗市场有何影响？
  • 主要区域市场有哪些？
  • 依类型划分市场是怎么样的？
  • 根据给药途径，市场的分化为何？
  • 基于应用的市场区隔是什么？
  • 基于配销通路的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球胃肠道治疗市场的结构如何？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球胃肠道治疗市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 品牌化
    • 市场趋势
    • 市场预测
  • 通用的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依管理途径

  • 口服
    • 市场趋势
    • 市场预测
  • 静脉
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按应用

  • 溃疡性结肠炎
    • 市场趋势
    • 市场预测
  • 克罗恩病
    • 市场趋势
    • 市场预测
  • 胃食道逆流症
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按配销通路

  • 医院药房
    • 市场趋势
    • 市场预测
  • 零售药局
    • 市场趋势
    • 市场预测
  • 网路药局
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • AbbVie Inc.
    • AstraZeneca Plc
    • Bausch Health Companies Inc.
    • Bayer Aktiengesellschaft
    • GlaxoSmithKline Plc
    • Janssen Biotech Inc. (Johnson & Johnson)
    • Novo Nordisk A/S
    • Pfizer Inc.
    • Sanofi SA
    • Takeda Pharmaceuticals
Product Code: SR112024A3069

The global gastrointestinal therapeutics market size reached US$ 46.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 69.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032.

Gastrointestinal (GI) syndrome refers to a medical ailment that affects the functioning of organs in the digestive tract. It impacts the stomach, pancreas, small and large intestines, gall bladder and liver and is usually characterized by indigestion, heartburn, constipation and bloating. Some of the commonly used GI therapeutics include prescription and over-the-counter (OTC) drugs, such as antacids, laxatives, antidiarrheal agents, antiemetics, antiulcer agents, and endoscopic and radiological procedures and hematological tests. These therapeutics assist in the detection of the disorder and absorbing nutrients from the food to improve digestion, regulate water flow in the GI system and minimize gastric acidity.

The increasing prevalence of GI diseases, such as inflammatory bowel disease (IBD) and ulcerative colitis, is one of the key factors driving the growth of the market. Due to changing lifestyle patterns and unhealthy dietary habits, there is an increased probability of disease recurrence among patients across the globe. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. Various technological advancements, such as the development of innovative biosimilars and cellular therapies for the treatment of the disorder, are acting as other growth-inducing factors. These biologics are administered through intravenous and subcutaneous injections and are personalized for targeted treatments. Other factors, including rising health consciousness among the masses, extensive research and development (R&D) activities and significant improvements in the healthcare infrastructure, especially in developing economies, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global gastrointestinal therapeutics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, route of administration, application and distribution channel.

Breakup by Type:

Branded

Generic

Breakup by Route of Administration:

Oral

Intravenous

Others

Breakup by Application:

Ulcerative Colitis

Crohn's Disease

GERD

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer Aktiengesellschaft, GlaxoSmithKline Plc, Janssen Biotech Inc. (Johnson & Johnson), Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Takeda Pharmaceuticals.

Key Questions Answered in This Report:

  • How has the global gastrointestinal therapeutics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global gastrointestinal therapeutics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global gastrointestinal therapeutics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Gastrointestinal Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Branded
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Generic
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intravenous
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Ulcerative Colitis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Crohn's Disease
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 GERD
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 AbbVie Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 AstraZeneca Plc
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Bausch Health Companies Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Bayer Aktiengesellschaft
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 GlaxoSmithKline Plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Janssen Biotech Inc. (Johnson & Johnson)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Novo Nordisk A/S
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sanofi S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Takeda Pharmaceuticals
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Gastrointestinal Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Gastrointestinal Therapeutics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Gastrointestinal Therapeutics Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Gastrointestinal Therapeutics Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Gastrointestinal Therapeutics Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Gastrointestinal Therapeutics Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Gastrointestinal Therapeutics Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Gastrointestinal Therapeutics (Branded) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Gastrointestinal Therapeutics (Branded) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Gastrointestinal Therapeutics (Generic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Gastrointestinal Therapeutics (Generic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Gastrointestinal Therapeutics (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Gastrointestinal Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Gastrointestinal Therapeutics (Intravenous) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Gastrointestinal Therapeutics (Intravenous) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Gastrointestinal Therapeutics (GERD) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Gastrointestinal Therapeutics (GERD) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: North America: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: North America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Asia-Pacific: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Asia-Pacific: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Europe: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Europe: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Latin America: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Middle East and Africa: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Middle East and Africa: Gastrointestinal Therapeutics Market: Breakup by Country (in %), 2023
  • Figure 81: Middle East and Africa: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Global: Gastrointestinal Therapeutics Industry: SWOT Analysis
  • Figure 83: Global: Gastrointestinal Therapeutics Industry: Value Chain Analysis
  • Figure 84: Global: Gastrointestinal Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Gastrointestinal Therapeutics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 4: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Gastrointestinal Therapeutics Market: Competitive Structure
  • Table 8: Global: Gastrointestinal Therapeutics Market: Key Players